doc.ai

doc.ai is developing A.I. technologies to collect structured and real-world medical data to create engaging products, accelerate medical research and transform approaches to care. Their poly-omics data pipeline handles all forms of medical data to make it ready for analysis and model building.

The company's primary consumer offering is a medical research companion app for personal-omics collection and digital health trials where participants can earn financial rewards. Additionally, they license A.I. modules and create products for a portfolio of clients, including payors, pharma, providers and patient organizations.

doc.ai headquartered in United States, North America, operates in the Software, Artificial Intelligence (AI), Machine Learning, Health Care, Medical, Clinical Trials sector. The company focuses on Software and has secured $7.3B in funding across 168 round(s). With a team of 51-100 employees, doc.ai is actively contributing to advancements in Software. Their latest funding round, Seed Round - doc.ai, raised $5.0M. Discover more about their projects, partnerships, and impact on our platform.